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Disciplines
Pharmacy and Pharmaceutical Sciences

Comments
Presented at the AAPS Annual Meeting and Exposition in Orlando, Florida, October 2015.

Authors
Pradip Dhore, Suprit Saoji, Nishikant Raut, M. Bernardez, Rahul V. Haware, and Vivek S. Dave

This poster presentation is available at Fisher Digital Publications: https://fisherpub.sjf.edu/pharmacy_facpub/424

A solid dispersion based on milk-micelle as a drug-carrier for the enhancement of
the aqueous solubility of ritonavir
P. W. Dhore1, S. D. Saoji1, N. A. Raut1, M. Bernardez2, R. V. Haware3, V. S. Dave2
1Department

of Pharmaceutical Sciences, R. T. M. Nagpur University, Nagpur, Maharashtra, India
2Wegmans School of Pharmacy, St. John Fisher College, Rochester, NY, USA
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Objective

The goal of present investigation was to evaluate the feasibility of
formulating a solid-dispersion using milk-micelles as drugcarriers, to enhance the aqueous solubility of ritonavir.

Methods
Prototype solid dispersions of ritonavir with milk-micelles,
using various drug/carrier ratios (table 1) were prepared by
lyophilization technique. Additionally, physical mixtures of
ritonavir with the carrier were also prepared using similar ratios.
The influence of the drug/carrier ratio on the improvement of
ritonavir solubility was assessed by measuring the saturation
solubility of the solid dispersions at 37°C. Briefly, an excess
amount (~10 mg) of the prepared solid dispersion was placed in
a glass vial containing 5 ml of purified water. The vials were
sealed, and continuously shaken on rotary shaker at 37 °C for 48
hours. After 48 hours, the supernatant was collected, filtered
through a MilliporeTM filter (0.45 μm), suitably diluted, and
assayed on a UV-visible spectrophotometer, at 239 nm.
The solid dispersion with the optimized drug/carrier ratio
(based on the saturation solubility study) was selected to further
evaluate the drug-release behavior in phosphate buffer (pH: 6.8)
using USP apparatus II (paddle method).
Additionally, the prepared solid dispersions were
characterized by Fourier Transformed Infrared (FTIR)
Spectroscopy, Differential Scanning Calorimetry (DSC), Powder
X-Ray Diffraction (PXRD), and Scanning Electron Microscopy
(SEM).

Table 1: Apparent aqueous solubility of the samples
Drug: carrier ratio

Apparent aqueous solubility (µg/ml)*

Pure ritonavir
0.37 ± 0.03
1:1 (SD-1)
3.61 ± 0.02
1:2 (SD-2)
6.39 ± 0.05
1:3 (SD-3)
8.27 ± 0.06
1:4 (SD-4)
11.36 ± 0.06
1:5 (SD-5)
6.81 ± 0.03
* Data expressed as mean ± Std. Dev., n = 3

Figure 1: Influence of the drug: carrier ratio on the
dissolution of ritonavir. Data expressed as mean ± Std. Dev., n=3

Results

The formation of a solid dispersion was confirmed by the
disappearance of the ritonavir melting endotherm (DSC, 122°C),
and the FTIR peak (3000 cm-1) in the solid dispersion. The
measured values of apparent aqueous solubility of ritonavir, and
the prepared solid dispersions are shown in table 1.

Results (contd.)

The results showed that increasing levels of the carrier in the
solid dispersion resulted in a concomitant, and a significant
increase in the aqueous solubility of ritonavir. This increase in
the solubility was observed up to the drug: carrier ratio of 1:4,
beyond which, the solubility of ritonavir was found to decrease.
The drug: carrier ratio of 1:4 was thus considered optimal for the
prepared solid dispersion.
The in-vitro dissolution profiles of free ritonavir, and the
prepared solid dispersions are shown in figure 1. From the
results it was observed that, at the end of 120 min, free ritonavir
showed a ~10% release; whereas, ritonavir release from the
solid dispersions was found to increase progressively with an
increase in the carrier level.
This increase in the dissolution rate of ritonavir was observed
up to the drug: carrier ratio of 1:4 (> 98% ritonavir released in 2
hours). The drug release was found to be slower from the solid
dispersion with a drug/carrier ratio of 1:5.

Conclusions
The prepared solid dispersions showed a significant (up to
17-fold) enhancement in the apparent aqueous solubility, as well
as the dissolution behavior of ritonavir. Solid dispersions, using
milk micelle as a drug carrier can serve as potential alternative
strategy for enhancing the aqueous solubility of poorly water
soluble drugs such as ritonavir.

